Nordstjernan Acquires Finnish Diagnostics Company Aidian from Axcel-managed Funds

Axonius Acquires Cynerio

July 30, 2025

Cybersecurity

Axonius has acquired Cynerio, a specialist in medical-device and healthcare IoT security, to accelerate the company's expansion into the healthcare market. Deal terms were reported at about $180 million (potentially rising to $250 million on milestones), while Axonius' announcement described the transaction as "more than $100 million" in a cash-and-stock deal.

Nordic Consulting Acquires Hygeian

October 6, 2022

Healthcare Services

Nordic Consulting has acquired Hygeian, a UK-based healthcare consulting firm with a network of approximately 300 management consultants. The acquisition (Nordic's sixth) expands Nordic's presence and capabilities across the United Kingdom and the Middle East; Hygeian will continue to operate from its UK headquarters under the Hygeian brand as part of the Nordic Global family.

Nordstjernan Leads $28.5M Series B in Oden Technologies

April 10, 2024

AI & Machine Learning

Nordstjernan Growth led a $28.5 million Series B investment in Oden Technologies, a data and AI software provider for the manufacturing industry. New investors Flat Capital, Recurring Capital Partners and Oden customer INX International joined the round, with existing backers including Atomico and EQT Ventures also participating to support product development, Process AI expansion and customer growth in the U.S. market.

Hologic, Inc. Acquires Mobidiag Oy

June 17, 2021

Medical Devices

Hologic, Inc. has completed the acquisition of Mobidiag Oy, a Finnish developer of near‑patient molecular diagnostic instruments and tests, for approximately $808 million. The deal expands Hologic's diagnostics capabilities by adding Mobidiag's Amplidiag and Novodiag platforms for rapid, multiplexed acute‑care testing and broadens Hologic's global diagnostics footprint.

Apheon Acquires Majority Stake in Longwood

July 16, 2025

Medical Devices

Apheon, a pan‑European private equity investor, has acquired a majority stake in Longwood, a Zaragoza‑based distributor and manufacturer of high value‑added In‑Vitro Diagnostics (IVD) equipment and services focused on Next‑Generation Sequencing. Founder Antonio Raichs and CEO Miguel Giralt will remain invested and the partnership aims to expand Longwood's product offering, pursue M&A and accelerate international growth.

Mindray Acquires HyTest from Summa Equity for €545 Million

May 16, 2021

Medical Devices

Mindray has signed a definitive agreement to acquire HyTest, a Finland-based developer and manufacturer of high-performance antibodies and antigens for in-vitro diagnostics, from private equity owner Summa Equity for approximately €545 million. The deal, subject to customary regulatory approvals, is expected to close in the second half of the year and expands Mindray’s capabilities and product portfolio in IVD reagents and raw materials.